Gregory J. Kato - Concepedia

Author

Gregory J. Kato

National Heart Lung and Blood Institute ORCID

Also Known As

G J Kato, G Kato, G. J. Kato, G. Kato, G.J. Kato, GJ Kato, GREGORY J. KATO, Greg J. Kato, Greg Kato, Gregory J Kato

414

Publications

17.1K

Citations

H-Index

193

Concepts

All Affiliations

National Heart Lung and Blood Institute National Institutes of Health University of Pittsburgh Howard University National Institutes of Health Clinical Center

About

Gregory J. Kato is an author at National Heart Lung and Blood Institute specializing in medicine, hematology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	34	52	4.3K
2	Public Health	13	14	1.3K
3	Health Sciences	12	12	623
4	Natural Sciences	8	8	1.1K
5	Engineering	4	4	447

Gregory J. Kato

134

Publications

11.7K

Citations

H-Index

Page 1

	Year	Citations
Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease Gregory J. Kato, Vicki McGowan, Roberto F. Machado, Blood	2005	639
An amino-terminal c-myc domain required for neoplastic transformation activates transcription. Gregory J. Kato, J. Barrett, Manuel Villa‐Garcia, Molecular and Cellular Biology Human C-mycMolecular BiologyC-myc ProteinRas GeneAmino-terminal C-myc Domain	1990	404
Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin José Villagra, Sruti Shiva, Lori A. Hunter, Blood	2007	371
Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions Gregory J. Kato, Robert P. Hebbel, Martin H. Steinberg, American Journal of Hematology Vascular DiseaseVasculitisImmunologyPathologyNitric Oxide Bioavailability	2009	340
Diastolic Dysfunction Is an Independent Risk Factor for Death in Patients With Sickle Cell Disease Vandana Sachdev, Roberto F. Machado, Yukitaka Shizukuda, Journal of the American College of Cardiology Diastolic DysfunctionCardiovascular DiseaseHematologyIndependent Risk FactorPublic Health	2007	310
Max: functional domains and interaction with c-Myc. Gregory J. Kato, W M Lee, Linzi Chen, Genes & Development ChromatinFunctional DomainsEngineeringDomain TheoryTruncated C-myc Protein	1992	290
An Official American Thoracic Society Clinical Practice Guideline: Diagnosis, Risk Stratification, and Management of Pulmonary Hypertension of Sickle Cell Disease Elizabeth S. Klings, Roberto F. Machado, Robyn J. Barst, American Journal of Respiratory and Critical Care Medicine	2014	248
Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity Roberto F. Machado, Robyn J. Barst, Nancy A. Yovetich, Blood	2011	245
The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe Mehdi Nouraie, Janet Lee, Yingze Zhang, Haematologica	2012	217
Mortality in Adults With Sickle Cell Disease and Pulmonary Hypertension Alem Mehari, Mark T. Gladwin, Xin Tian, JAMA AgingEpidemiology Of AgingDr OlshanskyEconomics Of AgingPopulation Aging	2012	215

Page 1